A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India
Titel:
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India
Auteur:
Kulkarni, Prasad S Padmapriyadarsini, Chandrasekaran Vekemans, Johan Bavdekar, Ashish Gupta, Madhu Kulkarni, Praveen Garg, B S Gogtay, Nithya J Tambe, Muralidhar Lalwani, Sanjay Singh, Kiranjit Munshi, Renuka Meshram, Sushant Selvavinayagam, T S Pandey, Krishna Bhimarasetty, Devi Madhavi Ramakrishnan, S R Bhamare, Chetanraj Dharmadhikari, Abhijeet Vadakkedath, Rajeev Bonhomme, Cyrille J Thakar, Madhuri Kurle, Swarali N Kelly, Elizabeth J Gautam, Manish Gupta, Nivedita Panda, Samiran Bhargava, Balram Shaligram, Umesh Kapse, Dhananjay Gunale, Bhagwat